101 related articles for article (PubMed ID: 27492018)
1. Formulation of controlled-release pelubiprofen tablet using Kollidon(®) SR.
Song SH; Chae BR; Sohn SI; Yeom DW; Son HY; Kim JH; Kim SR; Lee SG; Choi YW
Int J Pharm; 2016 Sep; 511(2):864-75. PubMed ID: 27492018
[TBL] [Abstract][Full Text] [Related]
2. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
[TBL] [Abstract][Full Text] [Related]
3. New Hydrophilic Matrix Tablets for the Controlled Released of Chlorzoxazone.
Creteanu A; Lisa G; Vasile C; Popescu MC; Pamfil D; Lungu CN; Panainte AD; Tantaru G
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791175
[TBL] [Abstract][Full Text] [Related]
4. Sustained-release solid dispersion of pelubiprofen using the blended mixture of aminoclay and pH independent polymers: preparation and in vitro/in vivo characterization.
Lee YS; Song JG; Lee SH; Han HK
Drug Deliv; 2017 Nov; 24(1):1731-1739. PubMed ID: 29124978
[TBL] [Abstract][Full Text] [Related]
5. Modulation of microenvironmental pH for dual release and reduced in vivo gastrointestinal bleeding of aceclofenac using hydroxypropyl methylcellulose-based bilayered matrix tablet.
Kang WH; Nguyen HV; Park C; Choi YW; Lee BJ
Eur J Pharm Sci; 2017 May; 102():85-93. PubMed ID: 28263912
[TBL] [Abstract][Full Text] [Related]
6. A Three-Pulse Release Tablet for Amoxicillin: Preparation, Pharmacokinetic Study and Physiologically Based Pharmacokinetic Modeling.
Li J; Chai H; Li Y; Chai X; Zhao Y; Zhao Y; Tao T; Xiang X
PLoS One; 2016; 11(8):e0160260. PubMed ID: 27479702
[TBL] [Abstract][Full Text] [Related]
7. Development of an extended-release formulation of capecitabine making use of in vitro-in vivo correlation modelling.
Meulenaar J; Keizer RJ; Beijnen JH; Schellens JH; Huitema AD; Nuijen B
J Pharm Sci; 2014 Feb; 103(2):478-84. PubMed ID: 24311366
[TBL] [Abstract][Full Text] [Related]
8. The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets.
Grund J; Koerber M; Walther M; Bodmeier R
Int J Pharm; 2014 Jul; 469(1):94-101. PubMed ID: 24746409
[TBL] [Abstract][Full Text] [Related]
9. A formulation approach for development of HPMC-based sustained release tablets for tolterodine tartrate with a low release variation.
Cao QR; Choi JS; Liu Y; Xu WJ; Yang M; Lee BJ; Cui JH
Drug Dev Ind Pharm; 2013 Nov; 39(11):1720-30. PubMed ID: 23062115
[TBL] [Abstract][Full Text] [Related]
10. [Application of synthetic and semisynthetic polymers (Kollidon K30 and hydroxypropylmethylcellulose) as carriers of ketoprofen in solid oral prolonged-release dosage forms].
Linka W; Kot M; Kołodziejczyk M
Polim Med; 2016; 46(2):145-153. PubMed ID: 28397455
[TBL] [Abstract][Full Text] [Related]
11. Formulation and development of orodispersible sustained release tablet of domperidone.
Patil HG; Tiwari RV; Repka MA; Singh KK
Drug Dev Ind Pharm; 2016; 42(6):906-15. PubMed ID: 26472165
[TBL] [Abstract][Full Text] [Related]
12. Evaluation and comparison of five matrix excipients for the controlled release of acrivastine and pseudoephedrine.
Gu X; Fediuk DJ; Simons FE; Simons KJ
Drug Dev Ind Pharm; 2004; 30(10):1009-17. PubMed ID: 15595567
[TBL] [Abstract][Full Text] [Related]
13. Hot melt granulation: a facile approach for monolithic osmotic release tablets.
Panda RR; Tiwary AK
Drug Dev Ind Pharm; 2012 Apr; 38(4):447-61. PubMed ID: 21954892
[TBL] [Abstract][Full Text] [Related]
14. Physical properties and in vivo bioavailability in human volunteers of isradipine using controlled release matrix tablet containing self-emulsifying solid dispersion.
Tran PH; Tran TT; Piao ZZ; Vo TV; Park JB; Lim J; Oh KT; Rhee YS; Lee BJ
Int J Pharm; 2013 Jun; 450(1-2):79-86. PubMed ID: 23612354
[TBL] [Abstract][Full Text] [Related]
15. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
16. Effects of formulation variables and post-compression curing on drug release from a new sustained-release matrix material: polyvinylacetate-povidone.
Shao ZJ; Farooqi MI; Diaz S; Krishna AK; Muhammad NA
Pharm Dev Technol; 2001; 6(2):247-54. PubMed ID: 11416999
[TBL] [Abstract][Full Text] [Related]
17. Subcoating with Kollidon VA 64 as water barrier in a new combined native dextran/HPMC-cetyl alcohol controlled release tablet.
Castellanos Gil E; Iraizoz Colarte A; Lara Sampedro JL; Bataille B
Eur J Pharm Biopharm; 2008 May; 69(1):303-11. PubMed ID: 18053697
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of drug release from aged prolonged polyethylene oxide tablet matrices: effect of excipient and drug type.
Shojaee S; Kaialy W; Cumming KI; Nokhodchi A
Pharm Dev Technol; 2016 Mar; 21(2):189-95. PubMed ID: 25410967
[TBL] [Abstract][Full Text] [Related]
19. Development and characterisation of sustained release solid dispersion oral tablets containing the poorly water soluble drug disulfiram.
Shergill M; Patel M; Khan S; Bashir A; McConville C
Int J Pharm; 2016 Jan; 497(1-2):3-11. PubMed ID: 26608620
[TBL] [Abstract][Full Text] [Related]
20. Double-Layered Matrix of Shellac Wax-Lutrol in Controlled Dual Drug Release.
Phaechamud T; Choncheewa CE
AAPS PharmSciTech; 2016 Dec; 17(6):1326-1335. PubMed ID: 26694059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
